News
23h
Zacks.com on MSNCan UnitedHealth Really Fight Cost Headaches With $3.3B Amedisys Pill?
UNH's $3.3B Amedisys deal will likely clear DOJ hurdles with divestitures, aiming to tap fast-growing home healthcare amid ...
2d
GlobalData on MSNUnitedHealth’s $3.3bn Amedisys deal faces strict divestiture terms
UnitedHealth faced legal challenges last year when the US Justice Department and state attorneys general moved to block the ...
1d
Dealbreaker on MSNDOJ: UHG, Amedisys Must Divest 164 Locations for Acquisition to Proceed
The Department of Justice has reached a proposed settlement with UnitedHealth Group and Amedisys regarding UnitedHealth’s ...
UnitedHealth Group has agreed to sell off 164 hospice and home health locations to resolve U.S. antitrust concerns over its ...
In November, the DO J filed a lawsuit to challenge Amedisys' (NASDAQ: AMED) $101 a share sale to UnitedHealth (NYSE: UNH ...
Unitedhealth Group Inc. and home health and hospice care company Amedisys Inc. have reached a proposed a settlement with the ...
UnitedHealth Group and home health company Amedisys have reached a settlement with the federal government that will allow ...
The Department of Justice and state officials have reached a proposed settlement agreement with UnitedHealth Group and ...
The U.S. Justice Department said on Thursday it required broad divestitures to resolve a challenge to Unitedhealth’s $3.3 ...
UnitedHealth will sell 164 healthcare facilities in a DOJ settlement over its Amedisys deal while missing Q2 earnings and ...
The U.S. Department of Justice’s Antitrust Division has filed a proposed settlement requiring United Health to divest of at least 164 home health and hospice facilities to resolve the challenge to its ...
Amedisys' planned merger with UnitedHealth remains on the rocks, with regulatory overhang still an issue. Read why AMED stock ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results